Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105936

Local immune response in experimental pyelonephritis

James D. Lehmann, James W. Smith, Thomas E. Miller, Jack A. Barnett, and Jay P. Sanford

Department of Internal Medicine, The University of Texas Southwestern Medical School at Dallas, Dallas, Texas 75235

Veterans Administration Hospital, Dallas, Texas 75216

Find articles by Lehmann, J. in: PubMed | Google Scholar

Department of Internal Medicine, The University of Texas Southwestern Medical School at Dallas, Dallas, Texas 75235

Veterans Administration Hospital, Dallas, Texas 75216

Find articles by Smith, J. in: PubMed | Google Scholar

Department of Internal Medicine, The University of Texas Southwestern Medical School at Dallas, Dallas, Texas 75235

Veterans Administration Hospital, Dallas, Texas 75216

Find articles by Miller, T. in: PubMed | Google Scholar

Department of Internal Medicine, The University of Texas Southwestern Medical School at Dallas, Dallas, Texas 75235

Veterans Administration Hospital, Dallas, Texas 75216

Find articles by Barnett, J. in: PubMed | Google Scholar

Department of Internal Medicine, The University of Texas Southwestern Medical School at Dallas, Dallas, Texas 75235

Veterans Administration Hospital, Dallas, Texas 75216

Find articles by Sanford, J. in: PubMed | Google Scholar

Published November 1, 1968 - More info

Published in Volume 47, Issue 11 on November 1, 1968
J Clin Invest. 1968;47(11):2541–2550. https://doi.org/10.1172/JCI105936.
© 1968 The American Society for Clinical Investigation
Published November 1, 1968 - Version history
View PDF
Abstract

Experiments using an in vitro method of assessing protein synthesis by 14C amino acid incorporation were designed to determine whether pyelonephritic kidneys were capable of local antibody production. Unilateral pyelonephritis was produced in rabbits by intravenous injection of E. coli 0-75 while one ureter was transiently occluded. The capability of protein and immunoglobulin synthesis by pyelonephritic kidneys, contralateral kidneys, normal kidneys, and spleens from normal and pyelonephritic animals was measured.

Enhanced protein and immunoglobulin syntheses by pyelonephritic kidneys were first detected by the 11th day after infection and persisted through day 120. In individual experiments the pyelonephritic kidney produced 6-170 times more soluble protein than did the contralateral, uninfected kidney. In seven experiments, IgG comprised a mean of 72% of the total protein synthesized by the pyelonephritic kidney, compared with a mean of 19% in the contralateral kidney. IgA accounted for 10 and 9%, respectively. In these experiments 0.6-17% of the synthesized IgG was precipitable by somatic antigen of the E. coli 0-75.

The capability of the pyelonephritic kidney to synthesize soluble protein was quantitatively similar to that of spleens from infected animals. The proportion of synthesized protein which was immunoglobulin G, however, was greater in the pyelonephritic kidney than in the spleen. Furthermore, specific antibody synthesis by the pyelonephritic kidney persisted longer than did synthesis by the spleen of the same animal.

These studies provide evidence that in experimental pyelonephritis a significant local immune response occurs which is represented primarily by the production of IgG. Local immunoglobulin formation and specific antibody synthesis may be important factors in determining patterns of host resistance.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2541
page 2541
icon of scanned page 2542
page 2542
icon of scanned page 2543
page 2543
icon of scanned page 2544
page 2544
icon of scanned page 2545
page 2545
icon of scanned page 2546
page 2546
icon of scanned page 2547
page 2547
icon of scanned page 2548
page 2548
icon of scanned page 2549
page 2549
icon of scanned page 2550
page 2550
Version history
  • Version 1 (November 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts